ACT AlzChem Group

DGAP-News: AlzChem Group AG aims to enter a new market with Eminex(R), a product for more climate protection in agriculture

DGAP-News: AlzChem Group AG / Key word(s): Market Report
AlzChem Group AG aims to enter a new market with Eminex(R), a product for more climate protection in agriculture

13.09.2021 / 15:24
The issuer is solely responsible for the content of this announcement.


AlzChem Group AG aims to enter a new market with Eminex(R), a product for more climate protection in agriculture

- Distribution to start in 2021 and to be rolled out widely
- Significant reduction of methane and CO2 emissions in livestock farming possible

Trostberg, September 13, 2021 - AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, wants to take climate protection in agriculture to a new level with its new product Eminex(R). All over the world, livestock farming has been criticized for its poor environmental performance. In Germany alone, around 240,000 metric tons of methane and considerable amounts of CO2 escape in gaseous form from manure storage tanks every year. These methane emissions in particular are considered critical due to their impact on the climate, but are almost entirely avoidable. This is confirmed by recent studies conducted by DEKRA Assurance Services GmbH and the Leibniz Institute for Agricultural Engineering and Bioeconomy. According to these studies, methane and CO2 emissions during storage can be reduced by 90% to 100% by adding small quantities of the calcium cyanamide-based processing agent Eminex(R).

Andreas Niedermaier, CEO of AlzChem Group AG: "With Eminex(R) as an additive for blocking methane and CO2 emissions in agriculture, we are opening up a completely new global market. At the same time, agriculture is already an extremely well-developed target group for us, because we have a strong sales presence in this sector through our fertilizers. The conditions for market success are therefore excellent. We have the structural prerequisites and farmers are given a simple opportunity to make a significant leap in climate protection. The market could experience additional momentum above all if appropriate efforts were also made on the regulatory side."

Eminex(R) will be available in Germany and Austria from September 2021. Gradually, Switzerland and other European markets with intensive livestock farming will also be developed. Of particular interest to farmers is the fact that climate-protecting measures with Eminex(R) do not require any structural measures or investments in the storage and collection containers. In the future, farmers will thus be able to make a significant contribution to reducing the environmental impact associated with livestock farming quickly and without investment.

The AlzChem Group itself invests around EUR 19 million a year in measures to improve climate protection, according to the figures in the new Environmental Statement 2021. For example, in recent years, it has succeeded in reducing carbon dioxide emissions by 50,000 tons a year. In addition, the company aims to exceed the requirements of the German Federal Constitutional Court on the Climate Protection Act of April 29, 2021, via compensation measures for its own products. Eminex(R) is an important building block in this. In the medium term, the company has set itself the goal of becoming completely greenhouse gas neutral.

About AlzChem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, AlzChem products can offer attractive solutions with a wide range of different applications.

The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. AlzChem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.

The broad product range of AlzChem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company's response to global trends and developments. AlzChem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.

The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.



Contact:
Sabine Sieber
Head of Investor Relations & Communications


13.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone:
Fax:
E-mail:
Internet:
ISIN: DE000A2YNT30
WKN: A2YNT3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 1233024

 
End of News DGAP News Service

1233024  13.09.2021 

fncls.ssp?fn=show_t_gif&application_id=1233024&application_name=news&site_id=research_pool
EN
13/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AlzChem Group

Peter Thilo Hasler
  • Peter Thilo Hasler

Deutlicher Ausbau der Kreatin-Produktion

Gestern hat Alzchem den Beschluss über ein Investitionspro-gramm in Höhe von rund EUR 120 Mio. für den Neubau einer weitgehend automatisierten Produktionsanlage für Kreatin, dessen Vorprodukte und der vorgelagerten Infrastruktur be-kanntgegeben. Angabe gemäß wird aus diesem Projekt ein zusätzliches jährliches Umsatzpotenzial im unteren dreistelli-gen Millionenbereich erwartet. Die Inbetriebnahme der vom BMWE geförderten Kapazitätserweiterungsanlage soll stu-fenweise ab H2/2027e erfolgen. Das Kr...

Peter Thilo Hasler
  • Peter Thilo Hasler

Strategische Diversifikation ins Endkundensegment

Seit wenigen Wochen erweitert Alzchem die Produktlinie „High Protein Creatine“ des global tätigen Molkereiunternehmens Ehrmann (Umsatz 2024e ca. EUR 1,1 Mrd.) um Produkte mit Creavitalis. Dabei werden den Puddings, Drinks und Riegeln von Ehrmann jeweils 1,5 g des Kreatin-Produkts pro Portion zugefügt. Für Alzchem bedeutet die Vereinbarung eine gezielte OEM-Kooperation im Wachstumsmarkt für funktionelle Lebensmittel: Die Einbindung von Creavitalis in ein hochmargiges Handelsprodukt im Nährstoff-/...

Peter Thilo Hasler
  • Peter Thilo Hasler

Zum Halbjahr neue Höchstwerte bei Umsatz und Marge

Während das Basissegment Basics & Intermediates erwartungsgemäß rückläufig war (H1/2025 Umsatz EUR 78,2 Mio., -14,2% YoY), verzeichnete das margenträchtige Segment Specialty Chemicals im ersten Halbjahr 2025 ein Umsatzplus von 8,9% auf EUR 194,6 Mio. – getragen von einem Nachfrageaufschwung im Bereich Custom Manufacturing sowie einem weiterhin starken Geschäft mit Creapure im Bereich Human Nutrition. Der Umsatzanteil des Segments liegt mittlerweile bei 67,7% – Tendenz steigend und ist damit nach...

Peter Thilo Hasler
  • Peter Thilo Hasler

Weiterhin mit robustem Gewinnwachstum

Nach wie vor ist die Ertragsentwicklung von Alzchem von konjunkturellen Herausforderungen geprägt, profitiert aber in ungleich stärkerem Maße von der Verschiebung des Umsatz-Mix in das hochmargige Segment Specialty Chemicals. Weil deshalb die vorgelegten Zahlen zum ersten Quartal 2025 erneut über unseren Schätzungen sowie den Consensus-Erwartungen lagen und wir davon ausgehen, dass die höhermargigen Potenziale weiterhin abgeschöpft werden können, heben wir unser aus einem dreiphasigen DCF-Entity...

 PRESS RELEASE

EQS-News: Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung...

EQS-News: Alzchem Group AG / Schlagwort(e): Aktienrückkauf/Aktienrückkauf Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 - Zeitweilige Unterbrechung des Aktienrückkaufprogramms 17.03.2025 / 11:38 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Alzchem Group AG   Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052       Trostberg, 17. März 2025   Zeitweilige Unterbrechung de...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch